Taken together, the study results proposed that the HO-1-mediated molecular interventions might be a potential therapeutic scheme for obesity utilizing a natural nutraceutical like D. divaricata, nonetheless the in vivo effects of D. divaricata and its clinical importance remain to be clarified further (Figure 8). Here, HMOX1 is linked to obesity due to melanocortin 4 receptor deficiency.